Thousands of cancer researchers and clinicians are flocking to Chicago for the American Society of Clinical Oncology annual meeting that starts Friday. The ASCO meeting is where clinicians expect ...

AffyImmune Therapeutics has recorded what it says is the first documented complete response in a patient with a solid tumour treated with CAR-T therapy. The case comes from a phase 1 study of its ...

Pediatric cancer cure needs community & legislation In September last year, I was invited to moderate a panel discussion at ...

When asked on an “unaided basis” what they specifically wanted, the most common request was for additional safety information (57%) around cell therapies. CAR T-cell patients are treated at ...

TD Cowen 5th Annual Oncology Innovation Summit Tuesday, May 28 ... Allogene is developing a pipeline of “off-the-shelf” CAR T cell product candidates with the goal of delivering readily ...

Chimeric antigen receptor (CAR) T cells have a tough job. Engineered with a receptor that recognizes molecules decorating the surface of cancer cells, CAR T cells find and kill malignancies. However, ...

Bristol-Myers Squibb has shored up manufacturing of its CAR-T therapies, tapping into capacity at contract manufacturer Cellares that will be used to supply patients in the US, Europe, and Japan.

New drug combinations and sequences are being investigated and may improve outcomes for patients with newly diagnosed myeloma ...

June 14 (Reuters) - The European health regulator said on Friday cancer cell therapies known as CAR-T treatments must include a written warning of an associated risk for secondary blood cancers in ...

Survival rates have improved as advances develop in treatment, such as chimeric antigen receptor-T (CAR-T) cell therapy. Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app.

AstraZeneca and Daiichi Sankyo are looking at moving their antibody-drug conjugate Enhertu into another new breast cancer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...